Chemomab Therapeutics (CMMB) Reports In-Line Q1 EPS

Chemomab Therapeutics (NASDAQ: CMMB) reported Q1 EPS of ($0.04), in-line with the analyst estimate of ($0.04).

For earnings history and earnings-related data on Chemomab Therapeutics (CMMB) click here.

You May Also Be Interested In

• Klarna shares tumble on weak full-year revenue guidance
• Eltek Ltd (ELTK) Reports Q2 EPS of $0.41
• The free USDA tool that tracks egg prices at $0.62/dozen before your data vendor does